72 participants
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-17
- Start Date:
- 2020-08-12
- Completion:
- 2022-09-27
Conditions
- Malaria
Interventions
- DRUG